Skip to content
Search

Latest Stories

Pharmaceutical companies donate cash, medicine to Ukraine

In support of those affected by the war in Ukraine, pharmaceutical companies have come together to donate five-figure cash and source crucial supplies.

Redditch based independent wholesaler Lexon, which was formed in 1992 and works with independent pharmacies across the UK, has made a five-figure cash donation to the Disaster Emergency Committee’s Ukraine Humanitarian Appeal.


While Lexon’s ongoing charity activity usually focuses on causes local to its distribution centres across the UK, the exceptional circumstances in Ukraine prompted its management to make this significant donation.

It has also worked with Jade Pharmaceuticals to provide medicinal supplies to the support effort, to be distributed by a leading care organisation.

Anup Sodha, managing director at Lexon, said: “We are deeply saddened to witness events unfolding in the Ukraine and wanted to make a gesture to show our support in any way we can.

“Many of our staff across our distribution centres have expressed their desire to show some support for those impacted and we shared that sentiment.

“Real, practical assistance is what is needed right now, so we are proud to contribute to the Disaster Emergency Committee, who are doing incredible work.

“We have a diverse team across our sites with people affected by this in different ways, so we will continue to offer support to individuals who want to carry out their own fundraising or provide aid packages.”

Neal Radia, owner of Jade Pharmacy -- a group of 20 community pharmacies based in North West London and Hertfordshire -- said: “We are proud to have offered support in any way we can, this is the right thing to do and I encourage anyone who can help at all to do so.”

The DEC’s appeal has raised more than £200million so far, with the organisation saying it is ‘grateful to everyone who is giving, organising events and helping to spread the word.’

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less